Profile
Marco Aveggio Merello has worked as a Director at Grupo Wiese and ZEV Biotech.
Marco Aveggio Merello active positions
| Companies | Position | Start |
|---|---|---|
Grupo Wiese
 Grupo Wiese Financial ConglomeratesFinance Grupo Wiese operates as a group of companies that provides investment management services. Its service portfolio includes real estate, shipping, financial, insurance, and logistics sector. The company was founded by Augusto Wiese Eslava and is headquartered in Lima 27, Peru. | Director/Board Member | - |
ZEV Biotech
 ZEV Biotech Medical SpecialtiesHealth Technology ZEV Biotech is an Argentinean biotechnology company that specializes in molecular diagnostic kits for hereditary and infectious diseases, as well as pharmacogenomics of polar iris medicines technology. The company is based in Buenos Aires, Argentina. The company's technology is easy and cost-effective to implement in any laboratory, hospital, clinic, or other health institutions, both public and private, and adapts to the requirements of each one. The company was founded in 2014 by Maximiliano Irisarri, who has been the CEO since 2014. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Grupo Wiese
Grupo Wiese Financial ConglomeratesFinance Grupo Wiese operates as a group of companies that provides investment management services. Its service portfolio includes real estate, shipping, financial, insurance, and logistics sector. The company was founded by Augusto Wiese Eslava and is headquartered in Lima 27, Peru. | Finance |
ZEV Biotech
ZEV Biotech Medical SpecialtiesHealth Technology ZEV Biotech is an Argentinean biotechnology company that specializes in molecular diagnostic kits for hereditary and infectious diseases, as well as pharmacogenomics of polar iris medicines technology. The company is based in Buenos Aires, Argentina. The company's technology is easy and cost-effective to implement in any laboratory, hospital, clinic, or other health institutions, both public and private, and adapts to the requirements of each one. The company was founded in 2014 by Maximiliano Irisarri, who has been the CEO since 2014. | Health Technology |
- Stock Market
- Insiders
- Marco Aveggio Merello
